ACR 3.57% 5.8¢ acrux limited

Ignore the FDA and buy Acrux, page-24

  1. 150 Posts.
    lightbulb Created with Sketch. 3
    The FDA is concerned that there is little evidence that Testosterone Replacement Therapy is effective for age-related hypogonadism. Eli Lilly is currently sponsoring a clinical trial that could provide supporting evidence.

    http://www.clinicaltrials.gov/ct2/show/study/NCT01816295?term=TSAT&rank=37&view=record

    What are the odds of an industry-funded trial yielding positive results? Surely you cannot tell, right?
    Well, the cynical amongst us may suggest that it's 85%:

    http://www.salon.com/2013/01/27/bad_pharma_drug_research_riddled_with_half_truths_omissions_lies/
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.